53 filings
6-K
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
6-K
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
6-K
AMYT
Amryt Pharma Plc
23 Mar 23
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
9:00am
6-K
AMYT
Amryt Pharma Plc
16 Feb 23
Current report (foreign)
7:00am
6-K
AMYT
Amryt Pharma Plc
9 Jan 23
Current report (foreign)
4:05pm
6-K
g7s9vcyp16gfcuk5ml4
3 Jan 23
Current report (foreign)
6:05am
6-K
30tfqw
3 Nov 22
Current report (foreign)
7:44am
6-K
mrm t4heeko5c4
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
6w6 tba4cq
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
qeocnzuqgc1zjin3
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
s5puf 7ak3ge
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am
6-K
7sgj72
9 Jun 22
Current report (foreign)
7:17am
6-K
q32eq 8k7j3ka
1 Jun 22
Current report (foreign)
6:05am
6-K
qwvxcjeulkx0c
11 May 22
Current report (foreign)
4:30pm
6-K
6ke dnw509whmf
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
6-K
7ffksen4o 0d
31 Mar 22
Results of General Meeting
8:41am
6-K
qqpumb2sa4 dsflruqfv
16 Mar 22
Current report (foreign)
8:30am
6-K
8yeh3ojnb90zsd92evxv
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
yzidlmhy7p
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
tgvw8rajo
25 Feb 22
Current report (foreign)
4:05pm